vs
BALCHEM CORP（BCPC）与COMMERCE BANCSHARES INC（CBSH）财务数据对比。点击上方公司名可切换其他公司
COMMERCE BANCSHARES INC的季度营收约是BALCHEM CORP的1.8倍（$475.7M vs $263.6M），COMMERCE BANCSHARES INC净利率更高（29.8% vs 14.9%，领先14.9%），COMMERCE BANCSHARES INC同比增速更快（11.1% vs 9.8%），过去两年COMMERCE BANCSHARES INC的营收复合增速更高（7.1% vs 4.9%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
Commerce Bancshares, Inc.是总部位于美国密苏里州的区域性银行控股公司，在堪萨斯城和圣路易斯设有核心办公点，旗下Commerce Bank提供多元化金融服务，覆盖企业及个人银行、财富管理、关联公司投资等业务。
BCPC vs CBSH — 直观对比
营收规模更大
CBSH
是对方的1.8倍
$263.6M
营收增速更快
CBSH
高出1.3%
9.8%
净利率更高
CBSH
高出14.9%
14.9%
两年增速更快
CBSH
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $263.6M | $475.7M |
| 净利润 | $39.2M | $141.6M |
| 毛利率 | 35.6% | — |
| 营业利润率 | 19.8% | — |
| 净利率 | 14.9% | 29.8% |
| 营收同比 | 9.8% | 11.1% |
| 净利润同比 | 16.8% | 0.7% |
| 每股收益（稀释后） | $1.21 | $0.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCCBSH
| Q1 26 | — | $475.7M | ||
| Q4 25 | $263.6M | $449.4M | ||
| Q3 25 | $267.6M | $441.0M | ||
| Q2 25 | $255.5M | $445.8M | ||
| Q1 25 | $250.5M | $428.1M | ||
| Q4 24 | $240.0M | $422.1M | ||
| Q3 24 | $239.9M | $421.4M | ||
| Q2 24 | $234.1M | $414.5M |
净利润BCPCCBSH
| Q1 26 | — | $141.6M | ||
| Q4 25 | $39.2M | $140.7M | ||
| Q3 25 | $40.3M | $141.5M | ||
| Q2 25 | $38.3M | $152.5M | ||
| Q1 25 | $37.1M | $131.6M | ||
| Q4 24 | $33.6M | $136.1M | ||
| Q3 24 | $33.8M | $138.0M | ||
| Q2 24 | $32.1M | $139.6M |
毛利率BCPCCBSH
| Q1 26 | — | — | ||
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — |
营业利润率BCPCCBSH
| Q1 26 | — | — | ||
| Q4 25 | 19.8% | 40.8% | ||
| Q3 25 | 20.4% | 41.9% | ||
| Q2 25 | 20.1% | 44.0% | ||
| Q1 25 | 20.4% | 39.2% | ||
| Q4 24 | 19.8% | 41.2% | ||
| Q3 24 | 20.0% | 42.4% | ||
| Q2 24 | 19.6% | 43.4% |
净利率BCPCCBSH
| Q1 26 | — | 29.8% | ||
| Q4 25 | 14.9% | 31.3% | ||
| Q3 25 | 15.1% | 32.1% | ||
| Q2 25 | 15.0% | 34.2% | ||
| Q1 25 | 14.8% | 30.7% | ||
| Q4 24 | 14.0% | 32.2% | ||
| Q3 24 | 14.1% | 32.8% | ||
| Q2 24 | 13.7% | 33.7% |
每股收益（稀释后）BCPCCBSH
| Q1 26 | — | $0.96 | ||
| Q4 25 | $1.21 | $0.86 | ||
| Q3 25 | $1.24 | $1.06 | ||
| Q2 25 | $1.17 | $1.14 | ||
| Q1 25 | $1.13 | $0.98 | ||
| Q4 24 | $1.03 | $0.83 | ||
| Q3 24 | $1.03 | $1.01 | ||
| Q2 24 | $0.98 | $1.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.3B | $4.3B |
| 总资产 | $1.7B | $35.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BCPCCBSH
| Q1 26 | — | — | ||
| Q4 25 | $74.6M | — | ||
| Q3 25 | $65.1M | — | ||
| Q2 25 | $65.4M | — | ||
| Q1 25 | $49.9M | — | ||
| Q4 24 | $49.5M | — | ||
| Q3 24 | $73.7M | — | ||
| Q2 24 | $63.7M | — |
股东权益BCPCCBSH
| Q1 26 | — | $4.3B | ||
| Q4 25 | $1.3B | $3.8B | ||
| Q3 25 | $1.3B | $3.8B | ||
| Q2 25 | $1.3B | $3.6B | ||
| Q1 25 | $1.2B | $3.5B | ||
| Q4 24 | $1.1B | $3.3B | ||
| Q3 24 | $1.2B | $3.4B | ||
| Q2 24 | $1.1B | $3.1B |
总资产BCPCCBSH
| Q1 26 | — | $35.7B | ||
| Q4 25 | $1.7B | $32.9B | ||
| Q3 25 | $1.7B | $32.3B | ||
| Q2 25 | $1.7B | $32.3B | ||
| Q1 25 | $1.6B | $32.4B | ||
| Q4 24 | $1.6B | $32.0B | ||
| Q3 24 | $1.6B | $31.5B | ||
| Q2 24 | $1.6B | $30.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.3M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.72× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BCPCCBSH
| Q1 26 | — | — | ||
| Q4 25 | $67.3M | $645.1M | ||
| Q3 25 | $65.6M | $129.0M | ||
| Q2 25 | $47.3M | $111.2M | ||
| Q1 25 | $36.5M | $138.6M | ||
| Q4 24 | $52.3M | $577.9M | ||
| Q3 24 | $51.3M | $431.7M | ||
| Q2 24 | $45.0M | $147.4M |
自由现金流BCPCCBSH
| Q1 26 | — | — | ||
| Q4 25 | — | $592.4M | ||
| Q3 25 | — | $113.3M | ||
| Q2 25 | — | $100.5M | ||
| Q1 25 | — | $126.0M | ||
| Q4 24 | — | $531.7M | ||
| Q3 24 | — | $419.1M | ||
| Q2 24 | — | $138.9M |
自由现金流率BCPCCBSH
| Q1 26 | — | — | ||
| Q4 25 | — | 131.8% | ||
| Q3 25 | — | 25.7% | ||
| Q2 25 | — | 22.5% | ||
| Q1 25 | — | 29.4% | ||
| Q4 24 | — | 126.0% | ||
| Q3 24 | — | 99.5% | ||
| Q2 24 | — | 33.5% |
资本支出强度BCPCCBSH
| Q1 26 | — | — | ||
| Q4 25 | — | 11.7% | ||
| Q3 25 | — | 3.6% | ||
| Q2 25 | — | 2.4% | ||
| Q1 25 | — | 2.9% | ||
| Q4 24 | — | 10.9% | ||
| Q3 24 | — | 3.0% | ||
| Q2 24 | — | 2.1% |
现金转化率BCPCCBSH
| Q1 26 | — | — | ||
| Q4 25 | 1.72× | 4.59× | ||
| Q3 25 | 1.63× | 0.91× | ||
| Q2 25 | 1.23× | 0.73× | ||
| Q1 25 | 0.98× | 1.05× | ||
| Q4 24 | 1.56× | 4.25× | ||
| Q3 24 | 1.52× | 3.13× | ||
| Q2 24 | 1.40× | 1.06× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
CBSH
暂无分部数据
